Korro Bio KRRO
NASDAQ KRRO
$13.18 +0.22 (+1.70%)
At close: Aug 21, 2026 · 4:00 PM EDT

Korro Bio (KRRO) Other Non Operating Income (2018 - 2026)

Korro Bio's (KRRO) quarterly Other Non Operating Income came in at $906000.0 in Q1 2026, down 44.52% YoY from $1.6 million in Q1 2025, and down 8.48% on a QoQ basis from $990000.0 in Q4 2025.

Korro Bio (KRRO) Other Non Operating Income (2018 - 2026) Analysis & Trends

Korro Bio (KRRO) has 9 years of Other Non Operating Income data on file, last reported at $906000.0 in Q1 2026.

  • Quarterly Other Non Operating Income fell 44.52% year-over-year to $906000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.5 million (down 44.99% YoY) and the FY2025 annual result came in at $5.2 million, down 38.23% from the prior year.
  • Other Non Operating Income declined to $906000.0 in Q1 2026, from $990000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $2.3 million in Q2 2024 to a low of -$227000.0 in Q2 2022.
  • A 5-year average of $1.1 million and a median of $990000.0 in 2025 frame the typical range for Other Non Operating Income.
  • Annual changes were most pronounced in 2022 — Other Non Operating Income slumped 22600.0% — and 2023, when it surged 1557.58%.
  • Tracing KRRO's Other Non Operating Income over 5 years: stood at $619000.0 in 2022, then soared by 137.0% to $1.5 million in 2023, then surged by 32.52% to $1.9 million in 2024, then plunged by 49.07% to $990000.0 in 2025, then decreased by 8.48% to $906000.0 in 2026.
  • The last three Other Non Operating Income figures came in at $906000.0 (Q1 2026), $990000.0 (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Korro Bio 231.77 Mn 116.73 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 1.30 Mn
Mar 31, 2026 906,000.00
Dec 31, 2025 990,000.00
Sep 30, 2025 1.18 Mn
Jun 30, 2025 1.43 Mn
Mar 31, 2025 1.63 Mn
Dec 31, 2024 1.94 Mn
Sep 30, 2024 2.28 Mn
Jun 30, 2024 2.33 Mn
Mar 31, 2024 1.91 Mn
Dec 31, 2023 1.47 Mn
Sep 30, 2023 656,000.00
Jun 30, 2023 786,000.00
Mar 31, 2023 481,000.00
Dec 31, 2022 619,000.00
Sep 30, 2022 617,000.00
Jun 30, 2022 -227,000.00
Mar 31, 2022 -33,000.00
Sep 30, 2021 -139,000.00
Jun 30, 2021 -1,000.00